TickerFacts.

A business in context

NBP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-15 · 0002115245-26-000004

  2. 6-K · Current report

    Report date 2026-10-13 · 0001193125-26-419669

  3. 4 · Ownership change

    Report date 2026-09-17 · 0002089237-26-000008

  4. 4 · Ownership change

    Report date 2026-09-09 · 0002109966-26-000008

  5. 4 · Ownership change

    Report date 2026-09-03 · 0002109966-26-000006

  6. 6-K · Current report

    Report date 2026-09-08 · 0001193125-26-384356

  7. 6-K · Current report

    Report date 2026-09-08 · 0001193125-26-384355

  8. 4 · Ownership change

    Report date 2026-08-30 · 0002114309-26-000007

  9. 4 · Ownership change

    Report date 2026-08-22 · 0001992908-26-000013

  10. 6-K · Current report

    Report date 2026-06-30 · 0001193125-26-357819

  11. 6-K · Current report

    Report date 2026-08-20 · 0001193125-26-357817

  12. 6-K · Current report

    Report date 2026-07-24 · 0001193125-26-316242

  13. 6-K · Current report

    Report date 2026-07-13 · 0001193125-26-306688

  14. 4 · Ownership change

    Report date 2026-07-08 · 0002126029-26-000003

  15. 4 · Ownership change

    Report date 2026-07-08 · 0002114156-26-000003

  16. 6-K · Current report

    Report date 2026-06-29 · 0001193125-26-286812

  17. 20-F/A · Annual report

    Report date 2025-12-31 · 0001778016-26-000006

  18. 6-K · Current report

    Report date 2026-06-16 · 0001778016-26-000005

  19. 6-K · Current report

    Report date 2026-06-16 · 0001193125-26-271793

  20. 6-K · Current report

    Report date 2026-04-22 · 0001193125-26-168315

  21. 20-F · Annual report

    Report date 2025-12-31 · 0001778016-26-000002

  22. 6-K · Current report

    Report date 2026-04-07 · 0001193125-26-145700

  23. 6-K · Current report

    Report date 2026-03-16 · 0001193125-26-107313

  24. 6-K · Current report

    Report date 2026-03-09 · 0001193125-26-097536

  25. 6-K · Current report

    Report date 2026-03-03 · 0001193125-26-086892

  26. 6-K · Current report

    Report date 2026-02-25 · 0001193125-26-068546

  27. 6-K · Current report

    Report date 2026-02-19 · 0001193125-26-058080

  28. 6-K · Current report

    Report date 2026-02-17 · 0001193125-26-054569

  29. 6-K/A · Current report

    Report date 2026-02-06 · 0001193125-26-041170

  30. 6-K · Current report

    Report date 2026-02-06 · 0001193125-26-040355

  31. 6-K · Current report

    Report date 2026-01-22 · 0001193125-26-019417

  32. 6-K · Current report

    Report date 2026-01-22 · 0001193125-26-018662

  33. 6-K · Current report

    Report date 2026-01-16 · 0001193125-26-015342

  34. 6-K · Current report

    Report date 2026-01-06 · 0001193125-26-003444

  35. 6-K · Current report

    Report date 2025-09-30 · 0001193125-25-323791

  36. 6-K · Current report

    Report date 2025-12-10 · 0001193125-25-314328

  37. 6-K · Current report

    Report date 2025-12-03 · 0001193125-25-307454

  38. 6-K · Current report

    Report date 2025-10-31 · 0001193125-25-259310

  39. 6-K · Current report

    Report date 2025-10-29 · 0001193125-25-256922

  40. 6-K · Current report

    Report date 2025-10-29 · 0001193125-25-256295

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 3 transaction rows3AExercise / conversion: 12 transaction rows12MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

19 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-18
2026-09-21
Dennis Phillip AndrewS · Sale
Disposed
Ordinary Shares8209.00.71
2026-09-17
2026-09-21
Dennis Phillip AndrewM · Exercise / conversion
Acquired
Ordinary Shares23695.0n/a
2026-09-17
2026-09-21
Dennis Phillip AndrewM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
10302.00.0
2026-09-09
2026-09-11
Cao Sean WuxiongS · Sale
Disposed
Ordinary Shares107978.00.74
2026-09-03
2026-09-08
Cao Sean WuxiongM · Exercise / conversion
Acquired
Ordinary Shares104236.0n/a
2026-09-03
2026-09-08
Cao Sean WuxiongM · Exercise / conversion
Acquired
Ordinary Shares235136.0n/a
2026-09-03
2026-09-08
Cao Sean WuxiongM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
45320.00.0
2026-09-03
2026-09-08
Cao Sean WuxiongM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
102233.00.0
2026-08-31
2026-09-01
Xu Cong ClaireS · Sale
Disposed
Ordinary Shares3282.00.79
2026-08-30
2026-09-01
Xu Cong ClaireM · Exercise / conversion
Acquired
Ordinary Shares9382.0n/a
2026-08-30
2026-09-01
Xu Cong ClaireM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
4079.00.0
2026-08-22
2026-08-25
Lenz Robert A.M · Exercise / conversion
Acquired
Ordinary Shares17218.0n/a
2026-08-22
2026-08-25
Lenz Robert A.M · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
7486.00.0
2026-07-08
2026-07-10
Hagler Mark ArnoldA · Grant / award
Acquired
2025 Employee Share Option (right to buy)
Derivative security
949050.00.0
2026-07-08
2026-07-10
Lin Liwei LorraineA · Grant / award
Acquired
2025 Employee Share Option (right to buy)
Derivative security
254780.00.0
2026-07-06
2026-07-07
Xu Cong ClaireS · Sale
Disposed
Ordinary Shares4485.00.89
2026-07-06
2026-07-08
Gupta SrishtiA · Grant / award
Acquired
2025 Employee Share Option (right to buy)
Derivative security
3000000.00.0
2026-07-04
2026-07-07
Xu Cong ClaireM · Exercise / conversion
Acquired
Ordinary Shares12432.0n/a
2026-07-04
2026-07-07
Xu Cong ClaireM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
5405.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001778016NovaBridge Biosciences

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • I-Mab · former SEC name · 2019-07-29 to 2025-10-28

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗